New Dual Drugs Eliminate Tumors When Combined with Immunotherapy A groundbreaking combination therapy utilizing new dual drugs alongside immunotherapy has demonstrated the complete elimination of tumors in preclinical models, offering …
Tag:
Immunotherapy
-
-
Blood Pressure Drug Enhances Cancer Therapy Effectiveness A new Dartmouth Cancer Center (DCC) study, led by clinical researcher Tyler J. Curiel, MD, MPH, has found that the FDA-approved blood pressure …
-
Immunotherapy Advances Offer Latest Hope in Cancer Treatment A new generation of cancer treatments is emerging, driven by significant advances in immunotherapy. Recent research suggests a potential transformation in how …
-
AI-Powered Cancer Vaccine Saves Dog, Offers Hope for Human Treatments In a groundbreaking development, a Sydney tech entrepreneur utilized artificial intelligence to create a personalized mRNA cancer vaccine for his …
-
CD4+ T Cells: Reframing Cancer Immunotherapy For decades, cancer immunotherapy has largely focused on CD8+ cytotoxic T lymphocytes as the primary drivers of tumor cell destruction. However, emerging clinical evidence …
-
Iron Nanomaterial Shows Promise in Boosting Immunotherapy for Breast Cancer A novel approach combining iron supplementation with immunotherapy is demonstrating significant potential in the fight against breast cancer, according to …
-
Statins May Enhance Cancer Immunotherapy by Blocking Immune Suppression A common and affordable medication, statins, may significantly improve the effectiveness of cancer immunotherapy by disrupting a newly discovered mechanism that …
-
Dr. Soheil Meshinchi Named Dylan Burke Endowed Chair in Immunotherapy, Advancing Leukemia Treatment Fred Hutch Cancer Center has appointed Dr. Soheil Meshinchi as the second recipient of the Dylan Burke …
-
Rising Mortality in Immune Checkpoint Inhibitor Therapy: A Growing Concern Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, offering significant improvements in prognosis for many patients. Although, a growing body …
-
Natera and Bristol Myers Squibb Collaborate to Advance Lung Cancer Treatment with ctDNA Assay Natera, Inc. And Bristol Myers Squibb have joined forces to investigate the potential of Natera’s Signatera™ …